Sumitomo Mitsui Trust Holdings, Inc. Compugen LTD Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 26, 2022	SELL	$1.57 - $3.33 $787,942 - $1.67 Million	-501,874 Reduced 7.31%	6,363,945 $11.8 Million
Q1 2022 Apr 27, 2022	BUY	$2.76 - $4.64 $18.9 Million - $31.9 Million	6,865,819 New	6,865,819 $22.1 Million

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.